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Abstract
Background/Aims: Postoperative mortality and morbidity 
rates after hepato-pancreato-biliary (HPB) surgery remain 
high, and the number of elderly patients requiring such sur-
gery has been increasing. This study aimed to investigate 
postoperative outcomes of complex HPB surgery for elderly 
patients. Methods: We retrospectively reviewed periopera-
tive data of 721 patients who underwent complex HPB sur-
gery between 2010 and 2015. The patients were divided into 
2 groups: elderly (≥75 years) and non-elderly (< 75 years). 
Surgical outcomes of both groups were compared after pro-
pensity score-matching analysis. Subsequently, risk fac-
tors for serious postoperative morbidity were identified by 
multivariate analysis. Results: Before matching, the elder-
ly group (n = 170) had more comorbidities, such as cardio-
vascular and renal disease, than the non-elderly group (n = 
551). Matching yielded elderly (n = 170) and non-elder-
ly groups (n = 170) with similar preoperative backgrounds. 
The mortality and morbidity rates did not differ significantly 
between the groups. In multivariate analyses, operative time 
(OR 1.79; p = 0.005) and blood loss (OR 1.66; p = 0.03) were 
identified as independent risk factors for serious postopera-
tive morbidity, whereas older age did not have a predictive 
impact (OR 1.16; p = 0.52). Conclusions: Although elderly 
 patients had more comorbidities and higher incidences of 
postoperative mortality and several complications before 
matching, their postoperative outcomes were equivalent to 
those of non-elderly patients after matching.
© 2018 The Author(s) 
Published by S. Karger AG, Basel
Introduction
The complicated management of elderly patients with 
malignancy has become an important global issue. In-
creased life expectancy and the increasing number of el-
derly patients with cancer have resulted in expanded indi-
cations for hepato-pancreato-biliary (HPB) surgery [1]. 
However, the operative mortality and morbidity rates after 
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HPB surgery are still high. Although the 90-day mortality 
rate after complex HPB surgery has been decreasing, it was 
reported to be 1.7% in Japan [2]. Furthermore, nationwide 
surveys in Japan revealed that postoperative morbidity 
rates after major hepatectomy and pancreaticoduodenec-
tomy are 25.7 and 41.6% respectively [3, 4]. When consid-
ering the surgical indications for HPB surgery for older 
patients, we should also consider age-related mortality and 
morbidity and cancer-related death. However, there is lit-
tle evidence to support these approaches. 
To date, a nationwide survey in the United States 
showed that age (> 74 years) was associated with a nearly 
twofold increase in morbidity and mortality after HPB 
surgery [5]. Regarding hepatectomy, a previous literature 
review showed that surgical resection in elderly patients 
may be safe, and elderly patients had prognoses compa-
rable to those of younger patients [6]. However, the result 
of a nationwide survey performed in Japan revealed that 
older age was closely associated with mortality follow-
ing hepatectomy [7]. Regarding pancreatectomy, a previ-
ous literature review reported that although pancreatec-
tomy can be performed safely in an elderly population 
(≥80 years), overall morbidity and mortality rates were 
34.9 and 13.2% respectively [8].
Some studies have involved global perioperative out-
comes after HPB surgery [5, 9]. However, the relationship 
between age and perioperative outcomes has not been in-
vestigated extensively for patients undergoing HPB sur-
gery. Therefore, this study aimed to investigate the peri-
operative outcomes of complex HPB surgery by focusing 
on patient age and using a propensity score-matching 
(PSM) analysis and to subsequently examine risk factors 
for serious postoperative morbidity after HPB surgery. 
Methods
Study Cohort
We retrospectively reviewed the medical records of 721 con-
secutive patients who underwent complex HPB surgery at the 
Okayama University Hospital (Okayama, Japan) between January 
2010 and December 2015 (Table 1). Complex HPB surgery was 
defined according to the criteria of the Japanese Society of Hepato-
Biliary-Pancreatic Surgery [2]. The present study included 3 cate-
gories of procedures: hepatobiliary surgery, hepatopancreatic sur-
gery, pancreatic surgery. This study was approved by the Ethics 
Committee of the Okayama University Graduate School of Medi-
cine, Dentistry, and Pharmaceutical Sciences and was conducted 
in accordance with the Declaration of Helsinki.
Clinical Data
For enrolled patients, the following patient characteristics were 
evaluated as preoperative factors: age, sex (male, female), body 
mass index (BMI; ≤25, > 25), American Society of Anesthesiolo-
gists physical status (1–2, 3–4), laboratory values, liver function 
Table 1. Number of complex hepato-pancreato-biliary surgeries between 2010 and 2015 at the Okayama 
 University Hospital
Procedures Patients (n = 721), n
Hepatobiliary surgery
Right trisegmentectomy of the liver 9
Left trisegmentectomy of the liver 7
Right or extended right hepatectomy 64
Left or extended left hepatectomy 75
Central bisectionectomy of the liver 7
Hepatic sectionectomy (except lateral sectionectomy) 133
Hepatic segmentectomy (S1, S2, S3, S5, S6, S7, S8) 42
Hepatectomy (S4a + S5 or hemihepatectomy) with extrahepatic BDR 46
Extrahepatic BDR for congenital biliary dilatation 5
Hepatopancreatic surgery
Hepatopancreatectomy 13
Pancreatic surgery
Total pancreatectomy 8
Pancreatoduodenectomy 244
Distal pancreatectomy with lymph node dissection (for pancreatic cancer) 58
Middle segment pancreatectomy 9
Inferior pancreatic head resection 1
BDR, bile duct resection.
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according to the Child-Pugh score (A or B), comorbidities (hyper-
tension, diabetes, hyperlipidemia, cerebral disease, cardiac disease, 
chronic obstructive pulmonary disease), liver disease (hepatitis B 
virus and/or hepatitis C virus), chronic kidney disease, and etiol-
ogy of the disease (hepatic disease, biliary disease, pancreatic dis-
ease, or miscellaneous). Patients were divided into 2 groups ac-
cording to age, non-elderly (< 75 years) and elderly (≥75 years) 
according to the proposal of the Joint Committee of Japan Geron-
tological Society and the Japan Geriatrics Society [10]. 
Surgical procedures (Table 1), operative time, intraoperative 
blood loss, and blood transfusion were recorded as intraoperative 
outcomes. Details of the surgical techniques of hepatectomy, pan-
creaticoduodenectomy, and hepatopancreatectomy have been re-
ported previously [11–14]. At our center, age is not recognized as 
a contraindication. Patients, especially the elderly, meeting the fol-
lowing criteria were eligible for to undergo the following proce-
dures: ability to perform self-care, independent mobility, no severe 
dementia, and adequate family support. 
Postoperative outcomes, including postoperative 30- and 90-
day mortality, morbidity (any of the following events: reoperation, 
wound infection, intra-abdominal abscess, bile leakage, intraab-
dominal bleeding, central nervous system complication, cardiac 
complication, pneumonia, delirium, ileus, cholangitis, or bactere-
mia), and postoperative hospital stay, were evaluated. Postopera-
tive morbidity was assessed according to the American College of 
Surgeons National Surgical Quality Improvement Program crite-
ria [15] and graded according to the Clavien-Dindo classification 
[16]. Morbidity was defined according to Clavien-Dindo classifi-
cation ≥II, and serious morbidity was defined according to Cla-
vien-Dindo classification ≥III. 
Statistical Analysis
To avoid confounding differences due to baseline variability 
between the non-elderly and elderly groups, the PSM analysis was 
generated using a logistic regression model. Propensity scores 
were generated with preoperative variables with p < 0.20 (10 vari-
ables in total). This one-to-one matching was performed using a 
caliper width of 0.20 of the SD of the log of propensity score. We 
used the receiver-operating characteristic and area under the curve 
(AUC) to measure the balance of covariates. To investigate the im-
pact of perioperative predictors associated with serious postopera-
tive morbidity, we used a logistic regression model for univariate 
and multivariate analyses; ORs and 95% CIs were calculated. All 
preoperative and intraoperative variables with p < 0.20 in the uni-
variate analysis were selected for the multivariate analysis. All anal-
yses were performed with JMP version 11 software (SAS Institute, 
Cary, NC, USA). Student t test, Mann-Whitney’s U test, Fisher’s 
exact test, and the chi-square test were used appropriately. Two-
sided p < 0.05 was considered significant.
Results
Patient Characteristics
Patient characteristics before and after PSM are 
shown in Table 2. Of the overall cohort (n = 721), 170 pa-
tients (23.6%) belonged to the elderly group. The elderly 
group had more hypertension (p = 0.001), cardiac disease 
(p = 0.02), chronic obstructive pulmonary disease (p < 
0.001), and chronic kidney disease (p < 0.001). Malig-
nant diseases were significantly more frequent in the el-
derly group than in the non-elderly group (94.1 vs. 82.0%; 
p < 0.001).
After PSM, a non-elderly group (n = 170) with preop-
erative characteristics similar to those of the elderly group 
was selected. Within this matched cohort, the AUC cal-
culated from the receiver-operating characteristic curve 
was 0.724.
Perioperative Outcomes
Table 3 summarizes the intraoperative outcomes be-
fore and after PSM. In the PSM cohort, the operative time 
was significantly shorter for the elderly group (p = 0.003); 
however, other intraoperative factors did not differ sig-
nificantly. 
Concerning postoperative outcomes, the elderly group 
had higher rates of 90-day mortality (p < 0.001), wound in-
fection (p = 0.05), pneumonia (p = 0.02), and delirium (p < 
0.001) before PSM (Table 4). Regarding other factors, in-
cluding serious morbidity and 30-day mortality, there was 
no significant difference between groups. After PSM, no 
significant differences between groups were found regard-
ing the rates of postoperative 30-day mortality (0 vs. 0.6%; 
p = 0.32), 90-day mortality (3.5 vs. 0.6%; p = 0.06), serious 
morbidity (19.4 vs. 18.2%; p = 0.78), and any morbidity 
(61.8 vs. 59.4%; p = 0.66). Only the incidence of delirium 
was significantly higher for the elderly group (p < 0.001). 
Predictive Factors for Postoperative Serious Morbidity
Table 5 shows the results of the univariate and multi-
variate analyses used to identify the perioperative predic-
tors closely associated with serious postoperative mor-
bidity after HPB surgery. In the multivariate analysis, op-
erative time (OR 1.79; p = 0.005) and blood loss (OR 1.66; 
p = 0.03) were identified as independent risk factors as-
sociated with serious morbidity. However, age (≥75 years) 
was not an independent risk factor after complex HPB 
surgery (OR 1.16; p = 0.52).
Discussion
This retrospective study of 721 patients demonstrated 
that complex HPB surgery can be feasible, even for el-
derly patients. To the best of our knowledge, this study is 
the first to investigate the impact of age on global periop-
erative outcomes for patients following HPB surgery. Al-
though the elderly group had more comorbidities, they 
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had equivalent postoperative outcomes compared to 
non-elderly patients matched by propensity scores. In ad-
dition, age was not a risk factor for serious postoperative 
morbidity after HPB surgery.
Patient selection is important for minimizing postop-
erative morbidity or mortality after HPB surgery [5]. In 
our center, age is not recognized as a contraindication. 
We always considered the possibility of indications for 
procedures, even for the elderly, and patients underwent 
aggressive procedures regardless of age. However, the less 
extensive procedures for elderly patients were occasion-
ally considered according to the patients’ risks and tumor 
status. A more meticulous surgical approach would be 
necessary to shorten operative times and reduce blood 
loss as much as possible, especially for elderly patients. 
Accordingly, we suggested that individual assessment is 
most important for determining the strategy in accor-
dance with perioperative factors. 
Table 2. Characteristics of patients undergoing complex hepato-pancreato-biliary surgery: overall and propensity score-matching cohort
Variables Before PSM (n = 721) After PSM (n = 340)
non-elderly 
group (n = 551)
elderly 
group (n = 170)
p value non-elderly 
group (n = 170)
elderly 
group (n = 170)
p value
Gender, male/female 372/179 101/69 0.05 97/73 101/69 0.66
BMI (≤25, >25 kg/m2) 421/130 142/28 0.05 134/36 142/28 0.27
ASA (1–2, 3–4) 477/74 141/29 0.24 133/37 141/29 0.27
Hemoglobin, g/dL 13.2 (1.7) 12.7 (1.5) <0.001 12.7 (1.8) 12.7 (1.5) 0.96
Platelet count, ×104/μL 21.8 (8.1) 21.3 (7.6) 0.48 22.5 (8.5) 21.3 (7.6) 0.16
Total bilirubin, mg/dL 0.8 (0.6) 0.8 (0.5) 0.38 0.8 (0.8) 0.8 (0.5) 0.31
Albumin, g/dL 4.1 (0.5) 3.9 (0.4) <0.001 4.0 (0.6) 3.9 (0.4) 0.67
Prothrombin time 106 (15.9) 105 (18.3) 0.25 105 (16.3) 105 (18.3) 0.87
Child-Pugh score (A or B) 533/18 164/6 0.87 158/12 164/6 0.15
Comorbidities
Hypertension 234 (42.5) 96 (56.5) 0.001 105 (61.8) 96 (56.5) 0.32
Diabetes 174 (31.6) 61 (35.9) 0.30 63 (37.1) 61 (35.9) 0.82
Hyperlipidemia 181 (32.9) 65 (38.2) 0.20 74 (43.5) 65 (38.2) 0.32
Cerebral disease 30 (5.4) 10 (5.9) 0.83 12 (7.1) 10 (5.9) 0.66
Cardiac disease 52 (9.4) 27 (15.9) 0.02 24 (14.1) 27 (15.9) 0.65
COPD 84 (15.3) 54 (31.8) <0.001 54 (31.8) 54 (31.8) 1.00
Liver disease (HBV ± HCV) 142 (25.8) 37 (21.8) 0.29 43 (25.3) 37 (21.8) 0.44
CKD 79 (14.3) 51 (30.0) <0.001 49 (28.8) 51 (30.0) 0.81
Etiology of disease
Hepatic disease 264 (47.9) 75 (44.1) 0.01 75 (44.1) 75 (44.1) 0.65
Hepatocellular carcinoma 158 51 46 51
Metastatic hepatic cancer 54 11 17 11
Intrahepatic cholangiocarcinoma 34 13 9 13
Others 18 0 3 0
Biliary disease 72 (13.1) 34 (20.0) 28 (16.5) 34 (20.0)
Distal bile duct cancer 18 9 10 9
Perihilar or proximal bile duct cancer 16 8 5 8
Ampulla of vater cancer 14 8 6 8
Gall bladder cancer 13 8 4 8
Congenital bile duct dilatation 5 0 2 0
Others 6 1 1 1
Pancreatic disease 194 (35.2) 61 (35.9) 67 (39.4) 61 (35.9)
Pancreatic cancer 125 52 39 52
IPMN 35 7 16 7
Others 34 2 12 2
Miscellaneous 21 (3.8) 0 (0) 　 0 (0) 0 (0)
Data are presented as mean (SD) or n (%). 
PSM, propensity score matching; BMI, body mass index; ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; HBV, 
hepatitis B virus; HCV, hepatitis C virus; CKD, chronic kidney disease; IPMN, intraductal papillary mucinous neoplasm.
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Table 3. Intraoperative outcomes
Variables Before PSM (n = 721) After PSM (n = 340)
non-elderly group 
(n = 551)
elderly group
(n = 170)
p value non-elderly group 
(n = 170)
elderly group
(n = 170)
p value
Operative time, min 363 (112) 344 (107) 0.05 380 (111) 344 (107) 0.003
Blood loss, mL 737 (1383) 563 (638) 0.11 744 (1073) 563 (638) 0.06
Transfusion 85 (15.4) 29 (17.1) 0.61 36 (21.2) 29 (17.1) 0.33
Procedures
Hepatobiliary surgery 298 (54.1) 90 (52.9) 0.96 86 (50.6) 90 (52.9) 0.91
Right trisegmentectomy 9 0 3 0
Left trisegmentectomy 5 2 2 2
Right or extended right hepatectomy 56 8 16 8
Left or extended left hepatectomy 52 23 13 23
Central bisectionectomy 4 3 3 3
Hepatic sectionectomy (except lateral sectionectomy) 109 24 31 24
Hepatic segmentectomy (S1, S2, S3, S5, S6, S7, S8) 30 12 7 12
Hepatectomy (S4a+S5 resection or hemihepatectomy) 
with extrahepatic BDR 28 18 9 18
Extrahepatic BDR for congenital biliary dilatation 5 0 2 0
Hepatopancreatic surgery 10 (1.8) 3 (1.8) 3 (1.8) 3 (1.8)
Pancreatic surgery 243 (44.1) 77 (45.3) 81 (47.6) 77 (45.3)
Total pancreatectomy 7 1 1 1
Pancreatoduodenectomy 190 54 68 54
Distal pancreatectomy with LND 
(to treat pancreatic cancer) 38 20 10 20
Others 8 2 2 2
Vascular reconstruction 72 (13.1) 18 (10.6) 0.39 24 (14.1) 18 (10.6) 0.32
Data are presented as means (SD) or n (%). 
PSM, propensity score matching; BDR; bile duct resection; LND, lymph node dissection.
Table 4. Postoperative outcomes
Variables Before PSM (n = 721) After PSM (n = 340)
non-elderly group 
(n = 551)
elderly group
(n = 170)
p value non-elderly group 
(n = 170)
elderly group
(n = 170)
p value
30-day mortality 1 (0.2) 0 (0) 0.58 1 (0.6) 0 (0) 0.32
90-day mortality 2 (0.4) 6 (3.5) <0.001 1 (0.6) 6 (3.5) 0.06
Serious morbidity (CDc ≥III) 102 (18.5) 33 (19.4) 0.79 31 (18.2) 33 (19.4) 0.78
Any morbidity (CDc ≥II) 311 (56.4) 105 (61.8) 0.22 101 (59.4) 105 (61.8) 0.66
Reoperation 18 (3.3) 10 (5.9) 0.12 4 (2.4) 10 (5.9) 0.10
Wound infection 68 (12.3) 31 (18.2) 0.05 23 (13.5) 31 (18.2) 0.24
Intraabdominal abscess 50 (9.1) 17 (10.0) 0.77 14 (8.2) 17 (10.0) 0.57
Bile leakage 54 (9.8) 22 (12.9) 0.24 18 (10.6) 22 (12.9) 0.50
Intraabdominal bleeding 8 (1.5) 4 (2.4) 0.42 2 (1.2) 4 (2.4) 0.41
CNS complication 4 (0.7) 2 (1.2) 0.57 2 (1.2) 2 (1.2) 1.00
Cardiac complication 11 (2.0) 3 (1.8) 0.85 6 (3.5) 3 (1.8) 0.31
Pneumoniae 9 (1.6) 8 (4.7) 0.02 4 (2.4) 8 (4.7) 0.24
Delirium 39 (7.1) 43 (25.3) <0.001 17 (10.0) 43 (25.3) <0.001
Ileus 15 (2.7) 2 (1.2) 0.25 1 (0.6) 2 (1.2) 0.56
Cholangitis 18 (3.3) 6 (3.5) 0.87 7 (4.1) 6 (3.5) 0.78
Bacteremia 17 (3.1) 10 (5.9) 0.09 6 (3.5) 10 (5.9) 0.31
Postoperative hospital stay 24 (17–32) 24 (18–33) 0.26 24 (18–36) 24 (18–33) 0.33
Data are presented as median (range) or n (%). 
PSM, propensity score matching; CDc, Clavien-Dindo classification; CNS, central nervous system.
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Regarding the comparisons of patient characteristics 
between groups, 8 out of 18 preoperative factors showed 
significant differences before PSM (Table 2). As expected, 
elderly patients tended to have lower BMI values, lower 
hemoglobin and albumin levels, and more comorbidities. 
Elderly patients had more age-related comorbidities, with 
an average of 2.4 complications. Therefore, the surgical 
risk for elderly patients would be higher than that for 
non-elderly patients. Furthermore, indications for sur-
gery were significantly different. However, all differences 
in patient characteristics between groups disappeared af-
ter PSM. The covariate balance was considerably im-
proved in the matched cohort. 
Regarding the comparisons of intraoperative out-
comes between groups, no significant differences were 
found before PSM (Table 3). This suggested that complex 
HPB surgery is being aggressively performed for elderly 
patients at our institution. After PSM, elderly patients 
tended to have shorter operative times and less blood loss. 
This might reflect our meticulous surgical approach. We 
made it a priority to shorten operative times and reduce 
blood loss during HPB surgery for elderly patients. Per-
forming different procedures would also be a reason for 
the shorter operative times and reduced blood loss. For 
example, right trisegmentectomy, right or extended right 
hepatectomy, sectionectomy, and pancreatoduodenecto-
my were performed less often for the elderly group (not 
significant).
When we compared postoperative outcomes between 
groups, the 90-day mortality, pneumonia, and delirium 
rates were significantly higher for the elderly group before 
PSM. However, these differences, except for the incidence 
of delirium, disappeared after PSM. The main causes of 90-
day mortality for the 2 groups (n = 8) were as follows: post-
Table 5. Univariate and multivariate analyses of perioperative predictors associated with serious postoperative morbidity for patients 
undergoing complex hepato-pancreato-biliary surgeries
Variables Patients Events Univariate analysis Multivariate analysis
OR 95% CI p value OR 95% CI p value
Age (≥75 years) 170 33 1.06 0.68–1.63 0.79 1.16 0.73–1.80 0.52
Gender, male 473 100 1.63 1.08–2.51 0.02 1.48 0.97–2.30 0.068
BMI (≥25 kg/m2) 158 26 0.82 0.50–1.29 0.40
ASA (3–4) 103 22 1.21 0.71–2.00 0.47
Hemoglobin (<12 g/dL) 159 34 1.24 0.79–1.90 0.34
Albumin (<3.5 g/dL) 67 12 0.94 0.47–1.75 0.86
Child-Pugh score B 24 3 0.61 0.14–1.81 0.40
Hypertension 330 63 1.05 0.72–1.52 0.82
Diabetes 235 39 0.81 0.53–1.21 0.30
Hyperlipidemia 246 43 0.88 0.59–1.31 0.54
Cerebral disease 40 7 0.92 0.37–2.00 0.84
Cardiac disease 79 18 1.32 0.74–2.28 0.34
COPD 138 23 0.84 0.50–1.36 0.45
Liver disease (HBV ± HCV) 179 28 0.75 0.47–1.17 0.22
CKD 130 26 1.11 0.68–1.76 0.68
Etiology of disease
Hepatic disease 339 59 1
Biliary disease 106 27 0.62 0.37–1.05 0.07
Pancreatic disease 255 47 0.93 0.61–1.43 0.75
Miscellaneous 21 2 2 0.56–12.8 0.32
Operative time (>6 h) 323 80 2.05 1.41–3.02 <0.001 1.79 1.20–2.69 0.005
Blood loss (>1,000 mL) 131 37 1.98 1.27–3.04 0.003 1.66 1.05–2.60 0.031
Procedures
Hepatobiliary surgery 338 73 1
Hepatopancreatic surgery 13 3 0.77 0.23–3.01 0.71
Pancreatic surgery 320 59 1.03 0.70–1.50 0.90
Vascular reconstruction 90 24 1.7 1.01–2.80 0.05 1.31 0.75–2.23 0.33
BMI, body mass index; ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; HBV, hepatitis 
B virus; HCV, hepatitis C virus; CKD, chronic kidney disease.
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hepatectomy liver failure (n = 2) for the non-elderly group 
and post-hepatectomy liver failure (n = 2), gastrointestinal 
perforation (n = 2), pneumonia (n = 1), and postoperative 
bleeding (n = 1) for the elderly group. However, each pa-
tient finally experienced multiple organ failure. 
Our multivariate analysis revealed that age (≥75 years) 
was not a risk factor for serious postoperative complica-
tions. Although many perioperative factors have been re-
ported to have an impact on postoperative outcomes [5, 9], 
only intraoperative factors, including operative time and 
blood loss, were found to be risk factors for serious postop-
erative complications in the present study. These results 
supported previous findings that operative time and blood 
loss were independent predictors of adverse early outcomes 
following HPB surgery [9]. The reasons that serious post-
operative morbidities only depended on intraoperative fac-
tors rather than preoperative factors might be explained by 
the more invasive nature of the surgery. Accordingly, de-
creasing operative time and blood loss may decrease the 
risk of postoperative morbidities after HPB surgery. 
Perioperative strategies such as delirium management, 
nutrition, and mobilization may improve postoperative 
outcomes of patients undergoing HPB surgery. Postop-
erative delirium is a multifactorial and heterogeneous 
syndrome that is associated with increased morbidity and 
costs [17]. In the present study, elderly patients had a sig-
nificantly higher incidence of postoperative delirium. At 
our institution, the Delirium Management and Assess-
ment Center has participated in supporting perioperative 
delirium management [18], which would be effective for 
managing delirium. However, perioperative nutrition 
and mobilization are important components of periop-
erative care for pancreatic surgery and liver surgery and 
are recommended [19, 20]. Several literatures have shown 
the safety and efficiency of enhanced recovery after sur-
gery for improving short-term outcomes after HPB sur-
gery [21–25]. Among these literatures, some have in-
volved elderly patients; however, others have excluded 
the elderly. Further studies examining the effects of peri-
operative care on the elderly are needed to reduce mor-
bidity and mortality after HPB surgery. 
Despite our important findings, this study had a few 
limitations. This was a retrospective, single-center study; 
therefore, there may have been selection bias for the pa-
tients who underwent HPB surgery. Therefore, PSM was 
used to reduce selection bias in this study. PSM is now a 
widely accepted statistical approach that enables robust 
comparisons [26]. Furthermore, the AUC of 0.724 suggest-
ed acceptable discrimination [27]. Another limitation of 
this study was that PSM could not correct biases that were 
not measured as cofounders. In addition, this study includ-
ed different types of procedures. Intraoperative outcomes 
and postoperative morbidities would be expected to differ 
depending on the surgical procedure performed. However, 
the encouraging results of this study suggest that aging may 
not be a contraindication to complex HPB surgery. The 
present study did not examine patients who did not un-
dergo procedures; therefore, it might comprise only healthy 
elderly patients. Future studies are required to investigate 
the elderly patients who did and did not undergo surgery. 
Finally, we did not investigate the long-term outcomes af-
ter HPB surgery because we investigated several etiologies 
of diseases, including benign diseases. 
In conclusion, the present study demonstrated that age 
was not a risk factor for serious postoperative complica-
tions, even after complex HPB surgery. Although elderly 
patients had more comorbidities and higher incidences of 
postoperative mortality and several complications before 
PSM, they had outcomes similar to those of young pa-
tients after PSM. Careful patient selection and assess-
ments of surgical risks should be considered individually. 
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